• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    US Fertility Testing Market

    ID: MRFR/LS/14242-HCR
    100 Pages
    Rahul Gotadki
    September 2025

    US Fertility Testing Market Research Report By Product (Ovulation Predictor Kits, Fertility Monitors, Male Fertility Testing Products, others), By Sample (Saliva, Urine, Blood, others), By Mode of Purchase (Prescription-Based, OTC-Based) and By End-User (Home Care Settings, Hospitals, Fertility Clinics, others) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Fertility Testing Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    US Fertility Testing Market Summary

    The US Fertility Testing market is projected to grow from 136.5 million USD in 2024 to 400 million USD by 2035, reflecting a robust growth trajectory.

    Key Market Trends & Highlights

    US Fertility Testing Key Trends and Highlights

    • The market is anticipated to expand significantly, reaching 400 million USD by 2035.
    • From 2025 to 2035, the market is expected to grow at a compound annual growth rate of 10.27 percent.
    • In 2024, the market valuation stands at 136.5 million USD, indicating a strong foundation for future growth.
    • Growing adoption of advanced fertility testing technologies due to increasing awareness of reproductive health is a major market driver.

    Market Size & Forecast

    2024 Market Size 136.5 (USD Million)
    2035 Market Size 400 (USD Million)
    CAGR (2025-2035) 10.27%

    Major Players

    Progenity, Zywave, Cypress Diagnostics, CooperSurgical, LabCorp, Thermo Fisher Scientific, SomaLogic, Abbott Laboratories, Quest Diagnostics, Invitae, Ferring Pharmaceuticals, Merck KGaA, Everlywell, Natera, Bayer AG

    US Fertility Testing Market Trends

    The US Fertility Testing Market is currently seeing several significant trends shaped by societal, technological, and healthcare movements. A notable trend is the increasing awareness and demand for fertility testing among couples looking to conceive. This rise is partly influenced by the growing focus on reproductive health, especially among millennials and Generation Z. Additionally, there is a heightened acceptance of fertility issues, leading to more couples seeking proactive testing options.

    Key market drivers include advancements in technology, which have made home testing kits more accessible and user-friendly. These innovations enable individuals to carry out tests in the comfort of their own homes, thus removing some of the stigma associated with seeking help for fertility problems. Opportunities to be explored in this market include the development of more comprehensive testing kits that can address a broader range of fertility issues.

    These could incorporate biomarkers that provide insights into ovulation, sperm health, and overall reproductive health. Furthermore, there is potential for collaboration between fertility testing companies and healthcare providers to create integrated solutions that combine testing with personalized treatment advice. Recent trends also spotlight a shift towards personalized healthcare, where consumers are looking for tailored solutions based on their unique medical backgrounds.

    As telehealth services expand, many users are likely to seek online consultations coupled with at-home testing, thus transforming how fertility issues are addressed. Overall, these trends signify a changing landscape in the US Fertility Testing Market, with a focus on accessibility, personalization, and the integration of technology to support reproductive health.

    US Fertility Testing Market Drivers

    Market Segment Insights

    Fertility Testing Market Product Insights

    The US Fertility Testing Market for the Product segment is rapidly evolving, driven by advancements in technology and increasing awareness regarding reproductive health. Ovulation Predictor Kits are gaining popularity as they offer women precise tools to track their ovulation cycles, leading to improved chances of conception. These kits play a crucial role for couples trying to conceive, as they provide real-time data on fertility windows, facilitating better planning and timing.

    Another essential product in the market is Fertility Monitors, which cater to a growing consumer base seeking more comprehensive monitoring solutions. These monitors not only track ovulation but also provide insights into hormone levels and fertility trends, making them an attractive option for users looking for a thorough understanding of their reproductive health. Male Fertility Testing Products are also seeing significant traction, reflecting a growing awareness about male factors in infertility.

    As societal norms evolve, men are becoming more proactive in assessing their reproductive health, thus driving the demand for at-home testing options that allow them to monitor their sperm health without the stigma associated with clinical testing. Overall, these products represent a significant aspect of the US Fertility Testing Market and cater to a demographic that places high importance on reproductive planning and health monitoring.

    The growing trends in health consciousness and increased accessibility to these products are contributing to their acceptance and urging the industry toward further innovation. The concerted efforts by manufacturers to enhance product reliability and ease of use are anticipated to bolster market penetration. Additionally, government initiatives aimed at improving healthcare access and education on fertility health further support the potential growth of these product categories in the market landscape. As awareness around reproductive health challenges continues to grow, it creates a substantial opportunity for various products in the US Fertility Testing Market to expand their reach and impact among consumers.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Fertility Testing Market Sample Insights

    The US Fertility Testing Market encompasses various sample types, including saliva, urine, blood, and others, each playing a pivotal role in understanding reproductive health. Saliva-based tests are gaining traction due to their ease of use and non-invasive nature, which appeal to consumers seeking convenient home-testing options. Urine tests are widely recognized for their reliability in detecting ovulation, contributing significantly to the market as they facilitate family planning.

    Blood tests, although more invasive, provide critical hormone level assessments that are essential for comprehensive fertility evaluations, making them indispensable in clinical settings. The ongoing growth in the US Fertility Testing Market reflects increasing public awareness of fertility issues and a rising prevalence of conditions affecting reproductive health. This uptick is supported by broader societal shifts towards proactive health monitoring and self-care, with individuals empowered to take charge of their fertility journey.

    Despite challenges such as high costs and regulatory hurdles, the market is poised for considerable expansion, driven by continuous innovation in testing technologies and a surge in demand for at-home fertility solutions.

    Fertility Testing Market Mode of Purchase Insights

    The US Fertility Testing Market exhibits a diverse Mode of Purchase that caters to varying consumer preferences and needs. The market is primarily split into Prescription-Based and Over-The-Counter (OTC)-Based purchases, which are pivotal for customer accessibility. Prescription-Based options are often recommended by healthcare professionals and provide a sense of reassurance and clinical oversight, ensuring that users receive products tailored to their specific needs.

    Meanwhile, OTC-Based options are increasingly popular due to their ease of access and convenience, allowing consumers to initiate testing without medical appointments, which appeals to the growing number of individuals seeking to monitor their fertility at home. This shift towards OTC products is also supported by advancements in technology and increasing awareness surrounding fertility issues among the general public, leading to market growth.

    As more individuals in the US explore their fertility options, these channels become essential in facilitating timely access to testing solutions, ultimately reflecting the dynamics of the US Fertility Testing Market. With a rising emphasis on reproductive health in the US, both Prescription-Based and OTC-Based modalities serve critical functions in ensuring consumers have choices that best meet their lifestyle and personal healthcare needs.

    Fertility Testing Market End-User Insights

    The End-User segment of the US Fertility Testing Market plays a crucial role in shaping the landscape of fertility services. This segment encompasses various environments, including Home Care Settings, Hospitals, Fertility Clinics, and others, each contributing unique dynamics to the overall market. Home Care Settings have gained traction, driven by a growing preference for privacy and convenience among individuals seeking fertility solutions, allowing users to conduct tests discreetly.

    Hospitals continue to offer comprehensive care, providing advanced diagnostic tools and treatments, often playing a central role in managing complex fertility cases. Fertility Clinics are significant players that offer specialized services and personalized care tailored to individual patient needs, with many clients seeking expert assistance in achieving their reproductive goals. Meanwhile, other environments also contribute, serving diverse needs within the overall fertility landscape.

    As the US faces challenges such as a rising average maternal age and increased awareness of infertility, these settings are positioned to meet the escalating demand for effective fertility solutions. The integration of technology, such as telehealth and at-home testing kits, enhances access and convenience, further driving market growth. These trends indicate the evolving nature of the US Fertility Testing Market and underscore the importance of understanding the varying demands across different End-User categories.

    Get more detailed insights about US Fertility Testing Market

    Request Free Sample

    Regional Insights

    Key Players and Competitive Insights

    The US Fertility Testing Market has seen significant growth and diversification over recent years, driven by rising awareness of fertility issues and advancements in testing technologies. This market is characterized by various players offering an array of products, ranging from at-home testing kits to professional laboratory services. Companies in this sector have developed innovative solutions to cater to a diverse clientele, which includes individuals planning families and those coping with infertility challenges.

    The competitive landscape is influenced by factors such as regulatory approvals, product effectiveness, branding strategies, and partnerships that enhance distribution capabilities. Companies are also increasingly focusing on digital transformation to provide comprehensive online support and education, thereby improving customer engagement and satisfaction. Progenity has established a strong foothold in the US Fertility Testing Market, leveraging its position through innovative testing solutions and a robust product portfolio.

    The company specializes in providing advanced genetic testing that enables healthcare providers to deliver personalized care to their patients. Progenity’s strengths lie in its commitment to research and development, which has led to the creation of highly accurate and reliable testing products. Their strong collaborations with healthcare professionals and institutions enhance their market presence, ensuring that they remain at the forefront of fertility diagnostics. With a focus on quality and advanced technology, Progenity is well-positioned to address growing consumer needs in the fertility testing arena, solidifying its reputation as a trusted name in the industry.

    Zywave has also carved out an influential role in the US Fertility Testing Market, known for its emphasis on providing comprehensive fertility solutions. The company offers a range of key products and services, including online resources that facilitate better understanding and management of fertility issues. Zywave’s strengths are highlighted by its dedication to customer education and support, which fosters a loyal customer base.

    Recent mergers and acquisitions have enabled Zywave to enhance its service offerings and expand its market share, allowing it to provide a more extensive suite of fertility testing options to consumers. The company’s strategic initiatives focus on leveraging partnerships to enhance product distribution and clinical support, further solidifying its competitive edge in this rapidly evolving market.

    Key Companies in the US Fertility Testing Market market include

    Industry Developments

    The US Fertility Testing Market has been experiencing notable developments recently, particularly in the area of innovation and partnerships. Progenity continues to expand its portfolio, focusing on non-invasive genetic testing solutions aimed at improving fertility outcomes. Zywave has been enhancing its digital platforms to support fertility tracking and monitoring. Cypress Diagnostics introduced new diagnostic tests that have gained traction among fertility clinics.

    In terms of market dynamics, CooperSurgical and LabCorp are exploring collaborative efforts to streamline testing processes, which is expected to enhance patient access to fertility solutions. Thermo Fisher Scientific and SomaLogic are investing in advanced technologies to develop precision fertility testing products. Additionally, Abbott Laboratories and Quest Diagnostics have reported significant growth in their fertility testing services, reflecting an increased demand driven by the rising awareness regarding reproductive health.

    In a recent merger, Ferring Pharmaceuticals announced its acquisition of a niche fertility testing firm in May 2023, positioning itself to broaden its offerings in the fertility sector. The overall market is witnessing a growth trend, influenced by technological advancements and increased public interest, particularly among younger demographics concerned with fertility health.

    Market Segmentation

    Fertility Testing Market Sample Outlook

    • Saliva
    • Urine
    • Blood
    • others

    Fertility Testing Market Product Outlook

    • Ovulation Predictor Kits
    • Fertility Monitors
    • Male Fertility Testing Products
    • others

    Fertility Testing Market End-User Outlook

    • Home Care Settings
    • Hospitals
    • Fertility Clinics
    • others

    Fertility Testing Market Mode of Purchase Outlook

    • Prescription-Based
    • OTC-Based

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 123.9(USD Million)
    MARKET SIZE 2024 136.5(USD Million)
    MARKET SIZE 2035 400.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 10.268% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Progenity, Zywave, Cypress Diagnostics, CooperSurgical, LabCorp, Thermo Fisher Scientific, SomaLogic, Abbott Laboratories, Quest Diagnostics, Invitae, Ferring Pharmaceuticals, Merck KGaA, Everlywell, Natera, Bayer AG
    SEGMENTS COVERED Product, Sample, Mode of Purchase, End-User
    KEY MARKET OPPORTUNITIES Telehealth integration for consultations, Home testing kit innovation, Personalized fertility solutions, Affordable screening services, Increased awareness and education programs
    KEY MARKET DYNAMICS rising infertility rates, increased awareness of fertility, advancements in testing technology, growing acceptance of home testing, expanding fertility health insurance coverage
    COUNTRIES COVERED US

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    What is the expected market size of the US Fertility Testing Market in 2024?

    The US Fertility Testing Market is expected to be valued at 136.5 million USD in 2024.

    How much is the US Fertility Testing Market projected to grow by 2035?

    By 2035, the market is projected to reach a valuation of 400.0 million USD.

    What is the expected CAGR for the US Fertility Testing Market from 2025 to 2035?

    The expected CAGR for the US Fertility Testing Market from 2025 to 2035 is 10.268 percent.

    Which segment holds the largest market share in the US Fertility Testing Market?

    The Ovulation Predictor Kits segment is anticipated to dominate the market with a value of 45.0 million USD in 2024.

    What will be the market size for Male Fertility Testing Products by 2035?

    The Male Fertility Testing Products segment is projected to reach 80.0 million USD by 2035.

    Who are the key players in the US Fertility Testing Market?

    Major players include Progenity, Zywave, CooperSurgical, and LabCorp among others.

    What are some growth drivers for the US Fertility Testing Market?

    Rising infertility rates and increasing awareness about fertility testing are key growth drivers.

    What is the expected market size for Fertility Monitors in 2035?

    Fertility Monitors are expected to reach a market size of 100.0 million USD by 2035.

    How is the current market environment impacting the US Fertility Testing Market?

    Current market trends show a growing demand for home-based fertility testing solutions.

    What challenges does the US Fertility Testing Market face?

    Challenges include regulatory hurdles and competition from alternative reproductive technologies.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. US Fertility Testing Market, BY Product (USD Million)
    45. Ovulation Predictor Kits
    46. Fertility Monitors
    47. Male Fertility Testing Products
    48. others
    49. US Fertility Testing Market, BY Sample (USD Million)
    50. Saliva
    51. Urine
    52. Blood
    53. others
    54. US Fertility Testing Market, BY Mode of Purchase (USD Million)
    55. Prescription-Based
    56. OTC-Based
    57. US Fertility Testing Market, BY End-User (USD Million)
    58. Home Care Settings
    59. Hospitals
    60. Fertility Clinics
    61. others
    62. Competitive Landscape
    63. Overview
    64. Competitive Analysis
    65. Market share Analysis
    66. Major Growth Strategy in the Fertility Testing Market
    67. Competitive Benchmarking
    68. Leading Players in Terms of Number of Developments in the Fertility Testing Market
    69. Key developments and growth strategies
    70. New Product Launch/Service Deployment
    71. Merger & Acquisitions
    72. Joint Ventures
    73. Major Players Financial Matrix
    74. Sales and Operating Income
    75. Major Players R&D Expenditure. 2023
    76. Company Profiles
    77. Progenity
    78. Financial Overview
    79. Products Offered
    80. Key Developments
    81. SWOT Analysis
    82. Key Strategies
    83. Zywave
    84. Financial Overview
    85. Products Offered
    86. Key Developments
    87. SWOT Analysis
    88. Key Strategies
    89. Cypress Diagnostics
    90. Financial Overview
    91. Products Offered
    92. Key Developments
    93. SWOT Analysis
    94. Key Strategies
    95. CooperSurgical
    96. Financial Overview
    97. Products Offered
    98. Key Developments
    99. SWOT Analysis
    100. Key Strategies
    101. LabCorp
    102. Financial Overview
    103. Products Offered
    104. Key Developments
    105. SWOT Analysis
    106. Key Strategies
    107. Thermo Fisher Scientific
    108. Financial Overview
    109. Products Offered
    110. Key Developments
    111. SWOT Analysis
    112. Key Strategies
    113. SomaLogic
    114. Financial Overview
    115. Products Offered
    116. Key Developments
    117. SWOT Analysis
    118. Key Strategies
    119. Abbott Laboratories
    120. Financial Overview
    121. Products Offered
    122. Key Developments
    123. SWOT Analysis
    124. Key Strategies
    125. Quest Diagnostics
    126. Financial Overview
    127. Products Offered
    128. Key Developments
    129. SWOT Analysis
    130. Key Strategies
    131. Invitae
    132. Financial Overview
    133. Products Offered
    134. Key Developments
    135. SWOT Analysis
    136. Key Strategies
    137. Ferring Pharmaceuticals
    138. Financial Overview
    139. Products Offered
    140. Key Developments
    141. SWOT Analysis
    142. Key Strategies
    143. Merck KGaA
    144. Financial Overview
    145. Products Offered
    146. Key Developments
    147. SWOT Analysis
    148. Key Strategies
    149. Everlywell
    150. Financial Overview
    151. Products Offered
    152. Key Developments
    153. SWOT Analysis
    154. Key Strategies
    155. Natera
    156. Financial Overview
    157. Products Offered
    158. Key Developments
    159. SWOT Analysis
    160. Key Strategies
    161. Bayer AG
    162. Financial Overview
    163. Products Offered
    164. Key Developments
    165. SWOT Analysis
    166. Key Strategies
    167. References
    168. Related Reports
    169. US Fertility Testing Market SIZE ESTIMATES & FORECAST, BY PRODUCT, 2019-2035 (USD Billions)
    170. US Fertility Testing Market SIZE ESTIMATES & FORECAST, BY SAMPLE, 2019-2035 (USD Billions)
    171. US Fertility Testing Market SIZE ESTIMATES & FORECAST, BY MODE OF PURCHASE, 2019-2035 (USD Billions)
    172. US Fertility Testing Market SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2035 (USD Billions)
    173. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    174. ACQUISITION/PARTNERSHIP
    175. MARKET SYNOPSIS
    176. US FERTILITY TESTING MARKET ANALYSIS BY PRODUCT
    177. US FERTILITY TESTING MARKET ANALYSIS BY SAMPLE
    178. US FERTILITY TESTING MARKET ANALYSIS BY MODE OF PURCHASE
    179. US FERTILITY TESTING MARKET ANALYSIS BY END-USER
    180. KEY BUYING CRITERIA OF FERTILITY TESTING MARKET
    181. RESEARCH PROCESS OF MRFR
    182. DRO ANALYSIS OF FERTILITY TESTING MARKET
    183. DRIVERS IMPACT ANALYSIS: FERTILITY TESTING MARKET
    184. RESTRAINTS IMPACT ANALYSIS: FERTILITY TESTING MARKET
    185. SUPPLY / VALUE CHAIN: FERTILITY TESTING MARKET
    186. FERTILITY TESTING MARKET, BY PRODUCT, 2025 (% SHARE)
    187. FERTILITY TESTING MARKET, BY PRODUCT, 2019 TO 2035 (USD Billions)
    188. FERTILITY TESTING MARKET, BY SAMPLE, 2025 (% SHARE)
    189. FERTILITY TESTING MARKET, BY SAMPLE, 2019 TO 2035 (USD Billions)
    190. FERTILITY TESTING MARKET, BY MODE OF PURCHASE, 2025 (% SHARE)
    191. FERTILITY TESTING MARKET, BY MODE OF PURCHASE, 2019 TO 2035 (USD Billions)
    192. FERTILITY TESTING MARKET, BY END-USER, 2025 (% SHARE)
    193. FERTILITY TESTING MARKET, BY END-USER, 2019 TO 2035 (USD Billions)
    194. BENCHMARKING OF MAJOR COMPETITORS

    US Fertility Testing Market Segmentation

     

     

     

    • Fertility Testing Market By Product (USD Million, 2019-2035)

      • Ovulation Predictor Kits
      • Fertility Monitors
      • Male Fertility Testing Products
      • others

     

    • Fertility Testing Market By Sample (USD Million, 2019-2035)

      • Saliva
      • Urine
      • Blood
      • others

     

    • Fertility Testing Market By Mode of Purchase (USD Million, 2019-2035)

      • Prescription-Based
      • OTC-Based

     

    • Fertility Testing Market By End-User (USD Million, 2019-2035)

      • Home Care Settings
      • Hospitals
      • Fertility Clinics
      • others

     

     

     

     

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027